Dose Low Dose Ketamine in Casesarian
Prospective case-control observational study (n=150) comparing single-dose IV ketamine (0.5 mg/kg), ketamine plus midazolam, and saline placebo in patients undergoing caesarean section to evaluate postpartum depression and postoperative outcomes.
Detailed Description
This prospective case-control study will allocate 150 patients undergoing caesarean section under spinal anaesthesia into three groups: ketamine 0.5 mg/kg IV, midazolam pre-dose followed by ketamine 0.5 mg/kg IV, or 5 ml IV saline placebo.
Postpartum depression will be assessed with the Edinburgh Postpartum Depression Scale (EPDS) preoperatively and at 1, 2 and 4 weeks post partum; secondary outcomes include analgesic requirement and adverse effects such as dizziness, hallucinations, nausea and vomiting.
Study Protocol
Preparation
Dosing
Integration
Study Arms & Interventions
Ketamine
experimentalSingle IV bolus ketamine 0.5 mg/kg (diluted to 5 ml) given after cord clamping.
Interventions
- Ketamine0.5 mg/kgvia IV• single dose• 1 doses total
Diluted to 5 ml; given within 5 minutes after cord clamping.
Ketamine + midazolam
experimentalSingle IV midazolam pre-dose followed by ketamine 0.5 mg/kg (diluted to 5 ml) after cord clamping.
Interventions
- Compound0.0125 mg/kgvia IV• single dose
Midazolam given prior to ketamine (arm text lists 0.0125 mg/kg; another section lists 0.03 mg/kg — see laterInfo).
- Ketamine0.5 mg/kgvia IV• single dose• 1 doses total
Diluted to 5 ml; given after midazolam and after cord clamping.
Placebo
inactive5 ml IV physiological saline single dose.
Interventions
- Placebovia IV• single dose• 1 doses total
5 ml normal saline (placebo) given after cord clamping.
Participants
Inclusion Criteria
- Inclusion Criteria:
- American Society of Anesthesiologists II–III; 18–45 years; patients planned for cesarean section; patient requests cesarean with spinal anesthesia.
Exclusion Criteria
- Exclusion Criteria:
- Pathological obstetric complications; Hypertension; Contraindication for ketamine; Contraindication for spinal anaesthesia.
Study Details
- StatusUnknown status
- PhasePhase NA
- Typeobservational
- DesignNon-randomized
- Target Enrollment150 participants
- TimelineStart: 2024-06-01End: 2024-09-01
- Compounds
- Topic